Literature DB >> 22290178

Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.

Sónia C Correia1, Renato X Santos, Cristina Carvalho, Susana Cardoso, Emanuel Candeias, Maria S Santos, Catarina R Oliveira, Paula I Moreira.   

Abstract

Many epidemiological studies have shown that diabetes, particularly type 2 diabetes, significantly increases the risk to develop Alzheimer's disease. Both diseases share several common abnormalities including impaired glucose metabolism, increased oxidative stress, insulin resistance and deposition of amyloidogenic proteins. It has been suggested that these two diseases disrupt common cellular and molecular pathways and each disease potentiates the progression of the other. This review discusses clinical and biochemical features shared by Alzheimer's disease and diabetes, giving special attention to the involvement of insulin signaling, glucose metabolism and mitochondria. Understanding the key mechanisms underlying this deleterious interaction may provide opportunities for the design of effective therapeutic strategies. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22290178     DOI: 10.1016/j.brainres.2011.12.063

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  68 in total

Review 1.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

Review 2.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

3.  Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes.

Authors:  Xiaojuan Han; Liling Yang; Heng Du; Qinjian Sun; Xiang Wang; Lin Cong; Xiaohui Liu; Ling Yin; Shan Li; Yifeng Du
Journal:  Cell Mol Neurobiol       Date:  2015-09-10       Impact factor: 5.046

Review 4.  New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.

Authors:  Kai Long Zhong; Fang Chen; Hao Hong; Xuan Ke; Yang Ge Lv; Su Su Tang; Yu Bing Zhu
Journal:  Metab Brain Dis       Date:  2018-04-06       Impact factor: 3.584

5.  Changes in lactate content and monocarboxylate transporter 2 expression in Aβ₂₅₋₃₅-treated rat model of Alzheimer's disease.

Authors:  Weitian Lu; Juan Huang; Shanquan Sun; Siqin Huang; Shengwei Gan; Jin Xu; Mei Yang; Shiye Xu; Xuli Jiang
Journal:  Neurol Sci       Date:  2015-02-03       Impact factor: 3.307

Review 6.  Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.

Authors:  Ramesh Kandimalla; Vani Thirumala; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-08-25       Impact factor: 5.187

7.  Decrease in Adult Neurogenesis and Neuroinflammation Are Involved in Spatial Memory Impairment in the Streptozotocin-Induced Model of Sporadic Alzheimer's Disease in Rats.

Authors:  Taysa Bervian Bassani; Jéssica M Bonato; Meira M F Machado; Valentín Cóppola-Segovia; Eric L R Moura; Silvio M Zanata; Rúbia M M W Oliveira; Maria A B F Vital
Journal:  Mol Neurobiol       Date:  2017-06-16       Impact factor: 5.590

Review 8.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

Review 9.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

Review 10.  Sweet old memories: a review of the experimental models of the association between diabetes, senility and dementia.

Authors:  O B Akinola
Journal:  Metab Brain Dis       Date:  2016-07-22       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.